WallStreetZenWallStreetZen
NYSE: CRL

How to Buy Charles River Laboratories International Stock

Open Broker Account

Charles River Laboratories International Inc

Charles River Laboratories International is a diagnostic & research company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker CRL on the NYSE exchange.

Charles River Laboratories International stock last closed at $228.57, down 4.56% from the previous day, and has decreased 37.53% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.14 percentage points. Charles River Laboratories International stock is currently +26.03% from its 52-week low of $181.36, and -39.79% from its 52-week high of $379.65.

There are currently 50.88M shares of CRL outstanding. The market value of CRL is $11.63B. In the past 24 hours, 1.99M CRL shares were traded.

How to Buy Charles River Laboratories International Stock

Not sure how to invest in Charles River Laboratories International stock? Here's how.
  1. Choose where to buy Charles River Laboratories International stock: You need to pick an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Charles River Laboratories International stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected. It's the best place to buy CRL stock.
  3. Deposit funds into your investment account: Pick your method of payment and add your information.
  4. Evaluate Charles River Laboratories International stock: The Charles River Laboratories International ticker symbol is CRL. Is Charles River Laboratories International stock a good investment? Should you buy shares of CRL? How do CRL's underlying business fundamentals look? Do top analysts think Charles River Laboratories International is a good buy? Why has CRL's stock price moved recently? (Hint: Our stock market analysis website can help you understand if CRL is a good stock to buy).
  5. Make your CRL trade: Decide if you will purchase CRL shares at the current market price or use a limit order to buy CRL shares at a given price.
  6. Get notifications regarding your CRL investment: Create a watchlist to important notifications about your position in Charles River Laboratories International stock.

Step 1: Choose where to buy Charles River Laboratories International stock

You will need an online brokerage account to access the NYSE market and buy CRL stock.

A brokerage account is an investment account that allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by signing up for an account with eToro now.

Open eToro Account

Step 2: Open a brokerage account

Now that you've selected the right brokerage, the next step is to fill out some personal details so you are able to invest in CRL today.

How to Set Up a New Account on eToro

  1. Click here to get started.
  2. Provide your personal data to open your new brokerage account.
  1. Send your data by clicking the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your investment account

Check out this video walkthrough if you need help transferring funds into your investment account.

Get started with eToro today

Step 4: Evaluate Charles River Laboratories International stock

It's important to research stocks prior to buying, so you truly wrap your head around the risk and upside.

Charles River Laboratories International Numbers

CRL Price
$228.57
1w %
-5.19%
1y %
-37.53%
5y %
119.36%
P/E
26.52x
P/B
4.43x
P/S
3.07x
PEG
1.42x
Revenue
$3.78B
Earnings
$436.39M
Fore. Rev. Growth
7.42%
Fore. Earn. Growth
18.62%
Market Cap
$11.63B
Next Earnings
N/A
Next Dividend
N/A

Charles River Laboratories International Fundamentals

WallStreetZen was built to help average investors perform more in-depth fundamental analysis in less time.

You can view all of the due diligence checks on CRL's stock page.

What is the fair value of CRL stock?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge CRL's true value.

Using relative valuations measures:

  • CRL may be undervalued based on its P/E ratio of 26.52x, relative to Diagnostics & Research industry P/E ratio of 35.98x
  • CRL may be undervalued based on its P/B ratio of 4.43x, relative to Diagnostics & Research industry P/B ratio of 4.44x
  • CRL could be overvalued based on its PEG ratio of 1.42x

You can access more valuation research on CRL's stock here.

CRL Financial Health Summary

Passed Health Checks:

  • There are more short-term assets than short-term liabilities on the CRL balance sheet.
  • CRL earnings of $570.83M is not enough to cover its interest payments.

Failed Health Checks:

  • CRL profit margin has gone down from 11.6% to 11.5% in the past year.
  • CRL has a relatively high debt to equity ratio of 1.79.
  • Total CRL debt is higher than 5 years ago, relative to shareholder equity.
  • There are more long-term liabilities than short-term assets on the CRL balance sheet.
  • CRL's operating cash flow of $614.14M allows it to safely service it's debt of $3.31B.

Is it a good time to buy CRL stock?

Out of 13 Wall Street analysts who give ratings on CRL, the consensus analyst rating on CRL is a Strong Buy

Should I buy or sell CRL stock?

Based on 13 analysts offering ratings for Charles River Laboratories International Inc.
Strong Buy
Strong Buy
8 analysts 61.54%
Buy
2 analysts 15.38%
Hold
3 analysts 23.08%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Latest CRL Analyst Recommendations

Tycho Peterson, a top 16% analyst from JP Morgan maintains CRL with a strong buy rating and lowers their CRL price target from $280.00 to $275.00, on Nov 3, 2022.

Dan Leonard, a top 6% analyst from Credit Suisse maintains CRL with a buy rating and lowers their CRL price target from $285.00 to $280.00, on Nov 3, 2022.

Ricky Goldwasser, a top 2% analyst from Morgan Stanley maintains CRL with a hold rating and lowers their CRL price target from $250.00 to $241.00, on Nov 3, 2022.

David Windley, a top 4% analyst from Jefferies upgrades CRL to a strong buy rating and announces their CRL price target of $240.00, on Sep 30, 2022.

Katie Tryhane, a bottom 14% analyst from Credit Suisse initiates coverage on CRL with a buy rating and announces their CRL price target of $285.00, on Aug 25, 2022.

You can dive deeper into what analysts are forecasting on the Charles River Laboratories International stock forecast page.

CRL Technical Indicators

SMA10
239.12
SMA20
234.56
SMA50
214.64
SMA100
216.9
SMA200
236.1
MACD
6.44
MACD Signal
8.1
MACD Histogram
-1.66
RSI
49.11
Stochastic %K
52.29
Stochastic %D
59.75
StochRSI %K
3.84
StochRSI %D
11.95

CRL Performance Numbers

Last year, CRL earnings were $436.39M. During the last five year, CRL's earnings have grown by 15.63% per year. This was slower than the Diagnostics & Research industry average of 21.89%.

Last year, CRL revenue was $3.78B. During the last five year, CRL's revenue has gone up by 15.42% per year. This was slower than the Diagnostics & Research industry average of 16.43%.

You can analyze CRL's earnings and revenue performance here.

Are CRL executives and large shareholders buying or selling the stock?

In the past 12 months, executives and large shareholders at CRL have sold more shares than they have bought.

Michael Gunnar Knell, CSVPChief Accounting Officer of CRL, was the latest CRL insider to sell. They sold $212,544.45 worth of CRL shares on Nov 16, 2022.

Get more info about who owns CRL stock here.

Can I get consistent income from CRL stock?

No, Charles River Laboratories International doesn't provide an income stream by paying out dividends.

What do other traders have to say about CRL?

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Make your CRL trade

There are two main options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are usually fine.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a specific price, use a limit order.

Click the Open button and your broker will place the order.

If you require additional info about buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get notifications regarding your CRL investment

Now that you own some shares in CRL, you'll want to keep up with your company.

Add CRL to a watchlist to see the latest developments about your CRL stock.

CRL Feed

How to Buy Stock in Charles River Laboratories International

To summarize, here are the 6 steps you need to take to buy Charles River Laboratories International stock right now:

  1. Choose where to buy Charles River Laboratories International stock
  2. Open a brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Charles River Laboratories International stock
  5. Make your CRL trade
  6. Get notifications regarding your CRL investment

If you require a brokerage account, eToro is our favorite venue.

Get Started with eToro Today

If you want to monitor your new investment in Charles River Laboratories International, click below.

NYSE: CRL
$228.57-10.93 (-4.56%)
Updated Nov 30, 2022
Open eToro Account
NYSE: CRL
$228.57-10.93 (-4.56%)
Updated Nov 30, 2022
Open eToro Account

FAQ

How much does it cost to buy one Charles River Laboratories International share?

As of Nov 30, 2022, it costs $228.57 to buy one share of Charles River Laboratories International stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.438 shares of CRL.

Get Started with eToro Today

Is now a good time to buy Charles River Laboratories International stock?

According to 13 Wall Street analysts who monitor Charles River Laboratories International, their consensus recommendation is to buy Charles River Laboratories International stock.

What is the best way to buy Charles River Laboratories International stock?

The best way to buy Charles River Laboratories International stock is within a brokerage account on eToro.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.